[Effect of Vascunicol on cerebrovascular disorders].
D000368:Aged; D002302:Cardiac Output / Q000187:drug effects; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D004357:Drug Synergism; D004569:Electroencephalography; D004983:Ethanolamines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007294:Inositol / Q000627:therapeutic use*; D008297:Male; D008568:Memory; D008875:Middle Aged; D009460:Neurologic Examination; D009539:Nicotinic Acids / Q000627:therapeutic use; D013566:Sympathomimetics / Q000627:therapeutic use
D004983:Ethanolamines; D009539:Nicotinic Acids; D013566:Sympathomimetics; D007294:Inositol
Uber den Einfluss von Vascunicol auf Hirndurchblutungsstörungen.